世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
73期
10,15
,共2页
NSCLC%病理类型%预后%临床分析
NSCLC%病理類型%預後%臨床分析
NSCLC%병리류형%예후%림상분석
NSCLC%pathological type%prognosis%clinical analysis
目的:分析我院收治的186例非小细胞肺癌(NSCLC)患者的病理类型分布、预后状况等临床特点.方法:以我院2009年5月~2012年5月年间确诊、治疗的186例NSCLC患者的临床资料作研究对象,统计、分析上述NSCLC患者在患病类型、生存期等临床特点.结果: 186例NSCLC患者的患病类型包括鳞癌、腺癌、肺泡癌、大细胞癌等,其中鳞癌患者占52.7%(98/186),显著高于其它类型NSCLC患者所占比率(P<0.05).结论:根据不同病理类型NSCLC的临床症状特征、发病影响因素制定针对性的治疗、护理方案,可有效提高NSCLC患者的生存时间、显著改善预后,值得借鉴.
目的:分析我院收治的186例非小細胞肺癌(NSCLC)患者的病理類型分佈、預後狀況等臨床特點.方法:以我院2009年5月~2012年5月年間確診、治療的186例NSCLC患者的臨床資料作研究對象,統計、分析上述NSCLC患者在患病類型、生存期等臨床特點.結果: 186例NSCLC患者的患病類型包括鱗癌、腺癌、肺泡癌、大細胞癌等,其中鱗癌患者佔52.7%(98/186),顯著高于其它類型NSCLC患者所佔比率(P<0.05).結論:根據不同病理類型NSCLC的臨床癥狀特徵、髮病影響因素製定針對性的治療、護理方案,可有效提高NSCLC患者的生存時間、顯著改善預後,值得藉鑒.
목적:분석아원수치적186례비소세포폐암(NSCLC)환자적병리류형분포、예후상황등림상특점.방법:이아원2009년5월~2012년5월년간학진、치료적186례NSCLC환자적림상자료작연구대상,통계、분석상술NSCLC환자재환병류형、생존기등림상특점.결과: 186례NSCLC환자적환병류형포괄린암、선암、폐포암、대세포암등,기중린암환자점52.7%(98/186),현저고우기타류형NSCLC환자소점비솔(P<0.05).결론:근거불동병리류형NSCLC적림상증상특정、발병영향인소제정침대성적치료、호리방안,가유효제고NSCLC환자적생존시간、현저개선예후,치득차감.
Objective:to analyze the clinical characteristics of 186 cases of non small cell lung cancer (NSCLC) in our hospital, and to analyze the pathological type distribution and prognosis of patients with non-small cell lung cancer ().Methods: the clinical data of 186 patients with ~2012 who were diagnosed and treated in our hospital from May 2009 to May were studied. The clinical data of patients with NSCLC were analyzed. The clinical characteristics of the patients with NSCLC were analyzed. Results:the prevalence of NSCLC was 52.7% (P<0.05), including squamous cell carcinoma, adenocarcinoma, lung cancer, and large cell carcinoma, among which 186 (98/186) was significantly higher than that of other patients with NSCLC.Conclusion:according to the clinical symptoms of different pathological types of NSCLC, the influence factors of the development of targeted treatment, nursing, can effectively improve the survival time of patients with NSCLC, significantly improve the prognosis, it is worth learning.
